The results indicated that the elevation of Nt-proBNP, Hs-CRP, and Angiotensin II levels observed in the myocardial infarction experimental group was inhibited by anthocyanin treatment in a dose-dependent manner. This evidence concerns the gene AGT and myocardial infarction.